Who it serves
Professionals, distributors and institutions in human or animal health, depending on the product.
How the business works
Development and manufacturing must meet technical and approval requirements. Commercial activity combines a product portfolio, distribution channels and production capacity.
What drives this activity
Approved portfolio, demand, production capacity and development and manufacturing costs.
The business in practice
Selected products, companies and assets from corporate publications.
- A portfolio spanning therapeutic areas
Richmond presents infectious-disease, oncology and oncohaematology, cardiometabolic and neuroscience lines. They address different needs of patients, professionals and healthcare systems. The range describes its pharmaceutical activity without establishing each area’s share of sales.
Richmond · therapeutic areasConsulted
- In-house development, licensing and technology
The portfolio combines generics, biosimilars, licences and technology transfers. Richmond also describes formulations combining active ingredients in one tablet. Its business therefore involves development and technology agreements alongside manufacturing; each product requires its own commercial and regulatory assessment.
Richmond · development and portfolioConsulted
Its place in Laboratorios Richmond
Laboratorios Richmond combines drug development, manufacturing and marketing. Its therapeutic portfolio connects research and production capabilities with healthcare demand.
Economics of the whole company
Business economics · explained by La Plata
Customers, operations & revenue
Laboratorios Richmond develops, manufactures and markets medicines across therapeutic areas. Products combine formulation, controlled manufacturing and access to healthcare channels. Patients, prescribers and purchasers can be different parties, so medical demand, commercial sales and receipts need not coincide.
What shapes business performance
Medicine mix, inputs, plant utilisation and development spending affect profitability. New facilities or projects require capital ahead of sales. Announced capacity, approved products and actual commercial production should be distinguished, alongside inventory and collection periods.